SEC Form 4 · accession 0001013606-15-000094
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amanda L. DePalma
Officer — VP, Global Marketing
Period of report
May 28, 2015
Accepted (ET)
Jun 1, 2015 · 10:29 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 28, 2015 | A | 5,425 | $0.00 | A | 19,619 | D | |
| Common StockF2 | May 28, 2015 | A | 5,425 | $0.00 | A | 25,044 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF3 | $16.58 | May 28, 2015 | A | 13,575 | A | Jun 28, 2015 | May 28, 2025 | Common Stock | 13,575 | 13,575 | D |
Explanation of responses
- F1Time based restricted stock unit award.
- F2Performance restricted stock unit award based on a regulatory milestone.
- F3Options vest ratably over forty-eight months.